Eloralintide, Eloralintide, Eloralintide, Placebo to match LY, Eloralintide
J3R-MC-YDAO
Phase 3 small_molecule active
Quick answer
Eloralintide, Eloralintide, Eloralintide, Placebo to match LY, Eloralintide for Overweight, Obesity, Sleep Apnea, Obstructive is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Overweight, Obesity, Sleep Apnea, Obstructive
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active